Corneal implants and methods of use

• US 20060235513A1
• Filed: 04/18/2005
• Published: 10/19/2006
• Est. Priority Date: 04/18/2005
• Status: Abandoned Application

• Current Assignee: Francis W. Price Jr
• Original Assignee: Francis W. Price Jr
• Inventors: Price, Francis W. Jr.
• Application Number:
  US11/108,505
• Publication Number:
  US 20060235513A1
• Time in Patent Office: Days
• US Class Current: 623/5.120
• CPC Class Codes: A61F 2/147 Implants to be inserted in the stroma for refractive correction, e.g. ring-like implants

Abstract

An implant (20) for reshaping the cornea includes a peripheral ring structure (22) surrounding an inlay member (24) where the inlay member is anchored to the ring structure via a plurality of filaments (26). The implant is surgically positioned with the inlay member generally directly over an ectatic region of the cornea to provide direct re-contouring of the cornea. The inlay member can be provided with a predetermined optical curvature and/or prescriptions to further correct the patient'"'"'s vision.

Claims

1. A corneal implant comprising:

an interior member adapted to be implanted in a cornea and to reshape to an area of the cornea;

at least one curved body spaced from the interior member and at least partially surrounding the interior member; and

a plurality of connecting members spanning between the curved body and the interior member;

wherein the connecting members impart structural support to the interior member to remodel the cornea with the interior member when the device is implanted.

2. The implant of claim 1 wherein the at least one curved body has a characteristic size of between about 8 mm and about 12 mm.

3. The implant of claim 1 wherein the interior member is an inlay.

4. The implant of claim 3 wherein the inlay is permeable to oxygen and glucose when implanted in the cornea.

5. The implant of claim 4 wherein the at least one curved body is substantially more rigid than the inlay.

6. The implant of claim 1 wherein the interior member is an interconnected mesh.

7. The implant of claim 1 wherein the plurality of connecting members overlap each other.

8. The implant of claim 7 wherein the plurality of connecting members form an interconnecting mesh.

9. The implant of claim 8 wherein the interior member comprises an inlay and the interconnecting mesh covers the inlay.

10. The implant of claim 1 wherein the plurality of connecting members extend radially from the interior member to the at least one curved body.

11. The implant of claim 1 wherein the at least one curved body forms a ring completely surrounding the interior member.

12. The implant of claim 11 wherein the ring is composed of a plurality of interconnected segments.

13. The implant of claim 12 wherein the interconnections are unequally spaced about the ring.

14. The implant of claim 12 wherein the segments are positionable into a compact configuration during implantation.

15. The implant of claim 1 wherein the plurality of connecting members are under tension.

16. The implant of claim 3 wherein the inlay defines a prescription.

17. The implant of claim 3 wherein the inlay is plano refractive.

18. The implant of claim 3 wherein the inlay has a preselected curvature.

19. The implant of claim 3 wherein the at least one curved body defines a center and the interior member is offset from the center defined by the at least one curved body.

20. A method comprising:

reshaping the cornea of a patient by implanting in the cornea at least one curved body at least partially surrounding an interior member wherein a plurality of tensioned members span between the interior member and the at least one curved body.

21. The method of claim 20 wherein the interior member defines a preselected optical prescription.

22. The method of claim 20 wherein the interior member defines a preselected optical curvature.

23. The method of claim 20 wherein the patient has been diagnosed with at least one of keratoconus and pellucid marginal degeneration.

24. The method of claim 20 wherein the implanting is via a lamellar dissection of the cornea.

25. A corneal implant comprising:

an interior member adapted to receive an ecstatic portion of a cornea when implanted in an eye;

a plurality of thin members contacting the interior member; and

at least one curved member forming a substantial portion of a perimeter around the interior member and adapted to apply tension to the thin members to at least partially correct the ectasia with the interior member when implanted in the eye.

26. The implant of claim 25 wherein the interior member is permeable to oxygen.

27. The implant of claim 26 wherein the interior member is permeable to glucose.

28. The implant of claim 25 wherein the interior member is an inlay.

29. The implant of claim 28 wherein the inlay has at least one of a preselected optical curvature and a preselected optical prescription.

30. A corneal implant comprising:

a peripheral body forming at least a portion of a ring;

an interior member in the interior of the ring or portion thereof; and

a plurality of tensioned members spanning between the peripheral body and the interior member, the tensioned members having a thickness substantially less than a thickness of the peripheral body.

31. The implant of claim 30 wherein the ring or portion thereof has a characteristic outer dimension less than about 12 mm.

32. The implant of claim 30 wherein the ring or portion thereof has a characteristic outer dimension greater than about 8 mm

33. The implant of claim 32 wherein the ring or portion thereof has a characteristic outer dimension less than about 12 mm.

34. The implant of claim 30 wherein the ring or portion thereof is substantially circular.

35. The implant of claim 30 wherein the ring or portion thereof is not substantially circular.

36. The implant of claim 30 wherein at least one of peripheral body, the interior member or the tensioned members is coated or embedded with at least one therapeutic composition.

37. The implant of claim 36 wherein the therapeutic composition is selected from corticosteroids, growth factors, anti-neovascular signaling factors, non-steroidal anti-inflammatory drugs, collagen cross linking chemicals, and anti-metabolite drugs.